Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019Chiara Fanciulli, Marta Montero, Christian Manzardo et al.|HIV Medicine|2022Cited by 28
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, Estebán Martínez, José L Blanco et al.|The Lancet HIV|2025Cited by 22
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical TrialRocío Montejano, Fernando Calle, María Velasco et al.|Clinical Infectious Diseases|2022Cited by 20
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018Leire Pérez‐Latorre, Juan Berenguer, Rafael Micán et al.|Eurosurveillance|2021Cited by 19
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study groupJosé Ramón Blanco, Alicia González-Baeza, Ana Martinez‐Vicente et al.|HIV Medicine|2024Cited by 8